SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006674
Filing Date
2021-05-10
Accepted
2021-05-10 16:16:39
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20210331x10q.htm   iXBRL 10-Q 1781081
2 EX-31.1 cara-20210331xex31d1.htm EX-31.1 12194
3 EX-31.2 cara-20210331xex31d2.htm EX-31.2 11867
4 EX-32.1 cara-20210331xex32d1.htm EX-32.1 10184
  Complete submission text file 0001558370-21-006674.txt   8187701

Data Files

Seq Description Document Type Size
5 EX-101.SCH cara-20210331.xsd EX-101.SCH 54972
6 EX-101.CAL cara-20210331_cal.xml EX-101.CAL 58221
7 EX-101.DEF cara-20210331_def.xml EX-101.DEF 254937
8 EX-101.LAB cara-20210331_lab.xml EX-101.LAB 515299
9 EX-101.PRE cara-20210331_pre.xml EX-101.PRE 426423
10 EXTRACTED XBRL INSTANCE DOCUMENT cara-20210331x10q_htm.xml XML 1555990
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 21907428
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences